All News

Drug meets primary endpoint at 50 mg with reduction in low-density lipoprotein levels from the baseline in the ETESIAN phase 2b trial

Valbenazine (Ingrezza) is indicated for the treatment of adults with tardive dyskinesia.

Aftersun Aloe Vera naturally soothes sunburns, minor skin irritations, and abrasions.

Regeneron’s supplemental biologics license application for the drug targets patients aged 12 years and older.

Alpelisib is the first FDA-approved treatment for PROS, which is a range of rare conditions characterized by overgrowths and blood vessel anomalies.

Recent studies demonstrated that renal failure, proteinuria, and histologic renal lesions can be prevented by mineralocorticoid receptor antagonists.

Capital budgeting accompanies planning and is at the heart of very important decisions made from what can appear to be conflicting goals.

Conversations with pharmacists can directly influence consumer attitudes and behaviors prompted by OTC advertisements.

Roche’s Actemra/RoActemra is aimed at patients receiving systemic corticosteroids who require extracorporeal membrane oxygenation, mechanical ventilation, or supplemental oxygen.

The eye drop treats age-related blurry near vision in adults and is FDA-approved for once-daily administration.

Lumateperone (Caplyta) is used for the treatment of schizophrenia and bipolar depression.

Valtrex is a nucleoside analogue DNA polymerase inhibitor that can treat herpes virus infections.

OTC sleep aids may help treat an occasional sleepless night.

Evidence indicates that low-dose tramadol is a generally safe, effective, and fast-acting antidepressant for a substantial number of individuals suffering from depression.

Pharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.

The value of a patient-first approach and telehealth for addressing the complex health care coordination needs of patients with rare pulmonary diseases has never been more critical than during the COVID-19 pandemic.

Ruxolitinib (Opzelura; Incyte) is a Janus kinase inhibitor indicated for patients 12 years of age or older whose atopic dermatitis is inadequately controlled with topical prescription therapies or when those therapies are inappropriate.

The entire pharmacy profession and all those interested in medication safety need to coalesce around the need for systemic change in community pharmacy workplace environments.

Fremanezumab-vfrm is the second FDA-approved preventive migraine treatment that works by blocking the activity of calcitonin gene-related peptide.

Ten quiz questions to assess your knowledge on antipsychotic medications.

Lipitor is an inhibitor of HMG-CoA reductase indicated as an adjunct therapy to diet to treat high cholesterol and triglyceride levels.

Lidocaine is a local anesthetic that offers temporary relief of pain and itching.

Will expansions in scope of authority stick, or have the effectiveness and speed of pharmacy adoption of services moved the medical establishment to battle stations?

With therapeutics developing quickly in the cardiovascular space, pharmacists are more important than ever.

Pharmacy Times spoke with Dave Dixon, PharmD, to learn more about his presentation titled “New Pharmacologic Therapies for Heart Failure.

George MacKinnon, PhD, MS, RPh, FASHP, FNAP, discussed how a multi-pronged approach to burnout is necessary in the pharmacy environment.

Sirolimus is the first topical treatment to gain FDA approval for facial angiofibroma associated with tuberous sclerosis complex.

Oncology and specialty treatments advance alongside care.

Mavacamten is a first-in-class, oral, allosteric modulator of cardiac myosin being evaluated for the treatment of symptomatic obstructive hypertrophic cardiomyopathy.

Session at American College of Cardiology Scientific Sessions 2022 highlight treatments for symptomatic obstructive hypertrophic cardiomyopathy.